Download PDF

Other users also viewed these articles

Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain Mònica Monteagudo; Alexa Nuñez; Iryna Solntseva; Nafeesa Dhalwani; Alison Booth; Miriam Barrecheguren; Dimitra Lambrelli; Marc Miravitlles;
Arch Bronconeumol. 2021;57:205-13
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience Juan P. de-Torres; Ciro Casanova; José M. Marín; Carlos Cabrera; Marta Marín; Ana Ezponda; Borja G. Cosio; Cristina Martínez; Ingrid Solanes; Antonia Fuster; Myriam Calle; Germán Peces-Barba; Carolina Gotera; Nuria Feu-Collado; Alicia Marin; Ana Belén Alcaide; Matilde Sangro; Gorka Bastarrika; Bartolome R. Celli;
Arch Bronconeumol. 2024;60:10-5
The Accuracy of PUMA Questionnaire in Combination With Peak Expiratory Flow Rate to Identify At-risk, Undiagnosed COPD Patients Kang-Cheng Su; Yi-Han Hsiao; Hsin-Kuo Ko; Kun-Ta Chou; Tien-Hsin Jeng; Diahn-Warng Perng;
Arch Bronconeumol. 2024;60:737-45